Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Relevance of Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

NCT00495924 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT00495924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00495924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Relevance of Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2008
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, monitoring, immunologic, neoplasm circulating cells, pancreatic neoplasms, tumor markers, biological